TONIX PHARMACEUTICALS HOLDING CORP. Debt Instrument, Convertible, Conversion Price
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) had Debt Instrument, Convertible, Conversion Price of $0.30 per share as of 2012-12-31, per its 10-K filed 2014-03-28.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleConversionPrice1 · last filed 2014-03-28
- 2012-12-31: Debt Instrument, Convertible, Conversion Price $0.30; Debt Instrument, Convertible, Conversion Price as first filed $0.62.
- 2012-09-30: Debt Instrument, Convertible, Conversion Price $0.62.
- 2012-06-30: Debt Instrument, Convertible, Conversion Price $0.62.
- 2011-12-31: Debt Instrument, Convertible, Conversion Price $0.62.
| Period end | Debt Instrument, Convertible, Conversion Price | Debt Instrument, Convertible, Conversion Price as first filed |
|---|---|---|
| 2012-12-31 | $0.30 10-K · filed 2014-03-28 | $0.62 10-K · filed 2013-03-11 |
| 2012-09-30 | $0.62 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $0.62 10-Q · filed 2012-08-13 | |
| 2011-12-31 | $0.62 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |